Rainier Therapeutics is a privately-held biotechnology developing biologics to address medical conditions where there is significant unmet need. Our lead program is a human monoclonal antibody, B-701, that targets and blocks the activity of FGFR3 (fibroblast growth factor receptor 3) and is the most advanced FGFR3-specific antagonist in development.
View Top Employees from Rainier TherapeuticsWebsite | http://www.rainierrx.com |
Revenue | $6 million |
Funding | $85 million |
Employees | 2 (2 on RocketReach) |
Founded | 2010 |
Address | 1040 Davis St. # 202, San Leandro, California 94577, US |
Phone | (925) 413-6140 |
Industry | Biotechnology, Pharmaceutical Manufacturing, Drug Discovery, Pharmaceuticals, Healthcare |
Web Rank | 25 Million |
Keywords | Bioclin |
Competitors | BioLineRx, Corbus Pharmaceuticals, Crystax Pharmaceuticals / Oryzon Genomics, DelMar Pharmaceuticals, Vidac Pharma |
SIC | SIC Code 283 Companies, SIC Code 80 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies |
Looking for a particular Rainier Therapeutics employee's phone or email?
The Rainier Therapeutics annual revenue was $6 million in 2024.
2 people are employed at Rainier Therapeutics.
Rainier Therapeutics is based in San Leandro, California.
The NAICS codes for Rainier Therapeutics are [54171, 54, 541, 541711, 5417].
The SIC codes for Rainier Therapeutics are [283, 80, 28].